Sialyltransferase family members and cervix squamous cell carcinoma

European Journal of Gynaecological Oncology

Volumn 23, Issue 6, 2002, Pages 514-518

  Chen, C L ^a   Lee, W L ^a   Tsai, Y C ^a   Yuan, C C ^a   Ng, H T ^a   Wang, P H ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Prognosis; Sialyltransferase; Squamous cell carcinoma of the cervix

Indexed keywords

GLYCOLIPID; GLYCOPROTEIN; MEMBRANE PROTEIN; SIALIC ACID; SIALYLTRANSFERASE;

ARTICLE; CANCER INVASION; CATALYSIS; CELL MEMBRANE; CELL TRANSFORMATION; METASTASIS; ONCOGENE; PATHOPHYSIOLOGY; SIALYLATION; SQUAMOUS CELL CARCINOMA; ST SEGMENT; TUMOR CELL; UTERINE CERVIX CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM STAGING; RNA, MESSENGER; SIALYLTRANSFERASES; UTERINE CERVICAL NEOPLASMS;

EID: 0036949933     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Fukuda M.: "Cell surface carbohydrates: cell-type specific expression". In: Fukuda M., Hindsgaul O., editors. Molecular Glycobiology. Oxford: Oxford University Press; 1994, 1.
2. Thomas P.: "Cell surface sialic acid as a mediator of metastatic potential in colorectal cancer". Cancer J., 1996, 9, 1.
3. Petretti T., Kemmner W., Schulze B., Schlag P.M.: "Altered mRNA expression of glycosyltransferase in human colorectal carcinomas and liver metastases". Gut., 200, 46, 359.
4. Lowe J. B.: "Carbohydrate recognition in cell-cell interaction". In: Fukuda M., Hindsgaul O., editors. Molecular Glycobiology. Oxford, Oxford University Press. 1994, 163.
5. Schauer R.: "Sialic acids and their role as biological masks". Trends Biochem. Sci., 1985, 10, 357.
6. Kim Y. J., Kim K. S., Kim S. H., Kim C. H., Ko J. H., Choe I. S., et al.: "Molecular cloning and expression of human Gal β1,3GalNac α2,3-sialyltransferase (hST3GalII)". Bioch. Biophy. Res. Com., 1996, 228, 324.
7. Fukuda M.: "Possible roles of tumor-associated carbohydrate antigens". Cancer Res., 1996, 56, 2237.
8. Hakomori S.: "Tumor malignancy defined by aberrant glycosylation and shingo-(glyco)-lipid metabolism". Cancer Res., 1996, 56, 5309.
9. Dorudi S., Kinrade E., Marshall N. C., Feakins R., Williams N. S., Bustin S. A.: "Genetic detection of lymph node micrometastases in patients with colorectal cancer". Br. J. Surg., 1998, 85, 98.
10. Aubert M., Panicot L., Crotte C., Gibier P., Lombardo D., Sadoulet M. O., Mas E.: "Restoration of α (1.2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells". Cancer Res., 2000, 60, 1449.
11. Zhu Y., Srivatana U., Ullah A., Gagneja H., Berenson C. S., Lance P.: "Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro." Biochem. Biophys. Acta, 2001, 1536, 148.
12. Yamamoto H., Oviedo A., Sweeley C., Saito T., Moskal J.R.: "α 2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo". Cancer Res., 2001, 61, 6822.
13. Schneider F., Kemmner W., Haensch W., Franke G., Gretschel S., Karsten U., Schlag P. M.: "Overexpression of sialyltransferase CMP-sialic acid: Gal β1,3GalNAc-R α6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas". Cancer Res., 2001, 61, 4605.
14. Wang P. H., Lo W. L., Hsu C. C., Lin T. W., Lee W. L., Wu C. Y., Yuan C. C., Tsai Y. C.: "Different enzyme activities of sialyltransferases in gynecological cancer cell lines". Eur. J. Gynaecol. Oncol., 2002, 23, 221.
15. Wang P. H., Li Y. F., Juang C. M., Lee Y. R., Chao H. T., Tsai Y. C., Yuan C. C.: "Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix". Gynecol. Oncol., 2001, 83, 121.
16. Wang P. H., Li Y. F., Juang C. M., Lee Y. R., Chao H. T., Ng H. T., et al.: "Expression of sialyltransferase family members in cervical squamous cell carcinoma correlates with lymph node metastases". Gynecol. Oncol., 2002, in press.
17. Wu C. Y., Hsu C. C., Chen S. T., Tsai Y. C.: "Soyasaponin I, a potent and specific sialyltransferase inhibitor". Biochem. Biophy. Res. Communic., 2001, 284, 466.
18. Recchi M. A., Hebbar M., Hornez L., Harduin-Lepers A., Peyrat J. P., Delannoy P.: "Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer". Cancer Res., 1998, 58, 4066.
19. Recchi M. A., Harduin-Lepers A., Boilly-Marer Y., Verbert A., Delannoy P.: "Multiplex RT-PCR method for the analysis of the expression of human sialyltransferase: application to breast cancer cells". Glycoconj. J., 1998, 15, 19.
20. Brockhausen I., Yang J., Lehotay M., Ogata S., Itzkowitz S.: "Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression". Biol. Chem., 2001, 382, 219.
21. Kannagi R.: "Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer". Glycoconj. J., 1997, 14, 577.
22. Harduin-Lepers A., Recchi M.A., Delannoy P.: "1994, the years of sialyltransferase". Glycobiology, 1995, 5, 741.
23. Tsuji S.: "Molecular cloning and functional analysis of sialyltransferases". J. Biochem. (Tokyo), 1996, 120, 1.
24. Itzkowitz S. H., Yuan M., Montgomery C. K., Kjeldsen T., Takahashi H. K., Bigbee W. L., Kim Y. S.: "Expression of Tn, sialosyl-Tn, and T antigens inhuman colon cancer". Cancer Res., 1989, 49, 197.
25. Ura Y., Dion A. S., Williams C. J., Olsen B. D., Redfield E. S., Ishida M., et al.: "Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues". Int. J. Cancer, 1992, 50, 57.
26. Burchell J., Poulsom R., Hanby A., Whitehouse C., Cooper L., Clausen H., Miles D., Taylor-Papadimitriou J.: "An α2.3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas". Glycobiology, 1999, 9, 1307.
27. Matsuura N., Narita T., Hiraiwa N., Hiraiwa M., Murai H., Iwase T., et al.: "Gene expression of fucosyl- and sialyl-trans ferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer". Int. J. Oncol., 1998, 12, 1157.
28. Ito H., Hiraiwa N., Sawada-Kasugai M., Akamatsu S., Tachikawa T., Kasai Y., et al.: "Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues". Int. J. Cancer, 1997, 71, 556.
29. Yamada N., Chung Y. S., Takatsuka S., Arimota Y., Sawada T., Dohi T., Sowa M.: "Increased sialyl sialyl Lewis a expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line". Br. J. Cancer, 1997, 76, 582.
30. Kudo T., Ikehara Y., Togayachi A., Morosumi K., Watanabe M., Nakamura M., et al.: "Up-regulation of a set of glycosyltransferase genes in human colorectal cancer". Lab. Invest., 1998, 78, 797.
31. Dall'Olio F. D., Chiricolo M., Lau J. T. Y.: "Differential expression of the hepatic transcript of β-galactoside α2,6 sialyltransferase in human colon cancer cell lines". Int. J. Cancer, 1999, 81, 243.
32. Bosch J., Brossmer R., Kemmner W., Schlag P.: "Preparation and characterization of differently aggregated colorectal carcinoma cell subpopulations from surgical specimens". Cancer Detection Prevention, 1998, 22, 319.
33. Ogawa J. I., Inoue H., Koide S.: "α-2,3-sialyltransferase type 3N and α-1, 3-focosyltransferase type VII are related to sialyl Lewis synthesis and patient survival from lung carcinoma". Cancer, 1997, 79, 1678.
34. Ogawa J., Tsurumi T., Yamada S., Koide S., Shohtsu A.: "Blood vessel invasion and expression of sialyl Lewis and proliferation cell nuclear antigen in stage I non-small cell lung cancer". Cancer, 1993, 73, 1177.
35. Pousset D., Piller V., Bureaud N., Monsigny M., Piller F.: "Increased α-2, 6 sialylation of N-Glycans in a transgenic mouse model of hepatocellular carcinoma". Cancer Res., 1997, 57, 4249.
36. Liu F., Qi H. L., Chen H. L.: "Regulation of differentiation and proliferation-inducer on lewis antigens, α-fucosyltransferase and metatstic potential in hepatocarcinoma cells". Br. J. Cancer, 2001, 84, 1556.
37. Petretti T., Schulze B., Schlag P. M., Kemmner W.: "Altered mRNA expression of glycosyltransferases in human gastric carcinomas". Bioch. Biophy. Acta, 1999, 1428, 209.
38. Bergler W., Riedel F., Schwartz-Albiez R., Gross H. J., Hormann K.: "A new histobiochemical method to analyze sialylation on cell-surface glycoproteins of head and neck squamous-cell carcinomas". Eur. Arch. Oto-Rhino-Laryngol., 1997, 254, 437.
39. Yamamoto H., Saito T., Kaneko Y., Kersey D., Yong V. W., Bremer E. G., et al.: "α 2, 3-sialyltransferase mRNA and α 2, 3-linked glycoprotein sialylation are increased in malignant gliomas". Brain Res., 1997, 755, 175.
40. Kaneko Y., Yamamoto H., Kersey D. S., Colley K. J., Leestma J. E., Moskal J. R.: "The expression of Gal β 1,4GlcNAc α 2, 6 sialyltransferase and α 2,6-linked sialoglycoconjugates in human brain tumors". Acta Neuropathologica. 1996, 91, 284.
41. Fukushima K., Hara-Kuge S., Seko A., Ikehara Y., Yamashita K.: "Elevation of α 2→6 sialyltransferase and α 1→2 fucosyltransferase activities in human choriocarcinoma". Cancer Res., 1998, 58, 4301.
42. Okajima T., Fukumoto S., Miyazaki H., Ishida H., Kiso M., Furukawa K., et al.: "Molecular cloning of a novel α 2, 3-sialyltransferase (ST3Gal IV) that sialylates type II lactosamine structures on glycoproteins and glycolipids". J. Biol. Chem., 1999, 274, 11479.
43. Lee Y.C., Kjima N., Wada E., Kurosawa N., Nakaoka T., Hamamoto T., Tsuji S.: "Cloning and expression of cDNA for a new type of Gal β 1, 3GalNAc α 2, 3-sialyltransferase". J. Biol. Chem., 1994, 269, 10028.
44. Kurosawa N., Kojima N., Inoue M., Hamamoto T., Tsuji S.: "Cloning and expression of Gal β 1, 3GalNAc-specific GalNAc α 2, 6-sialyltransferase". J. Biol. Chem., 1994, 269, 19048.
45. Kurosawa N., Hamamoto T., Lee Y. C., Nakaoka T., Kojima N., Tsuji S.: "Molecular cloning and expression of GalNAc α 2, 6-sialyltransferase". J. Biol. Chem., 1994, 269, 1402.
46. Taniguchi A., Kaneta R., Morishita K., Matsumoto K.: "Gene structure and transcriptional regulation of human Gal β 1,4(3)GIcNAc α 2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line". Biochem. Biophy. Res. Communic., 2001, 287, 1148.
47. Chang P. Y.: "Cancer Registry Annual Report". R.O.C. Taipei: Department of Health R.O.C., 1996.
48. Yuan C. C., Wang P. H., Lai C. R., Yen M. S., Chen C. Y., Juang C. M.: "Prognosis-predicting system based on factors related to survival of cervical carcinoma". Int. J. Gynecol. Obstet., 1998, 63, 163.
49. Yuan C.C., Wang P.H., Lai C.R., Tsu E.J., Yen M.S., Ng H.T.: "Recurrence and survival analyses of 1,115 cervical cancer patients treated with radical hysterectomy". Gynecol. Obstet. Invest., 1999, 47, 127.
50. Yuan C. C., Wang P. H., Ng H. T., Li Y. F., Huang T. S., Chen C. Y., et al.: "Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation". Gynecol. Oncol., 2002, 85, 148.
51. Yuan C. C., Wang P. H., Ng H. T., Tsai L. C., Juang C. M., Chiu L. M.: "Both TPA and SCC-Ag levels are prognostic even in high risk stage IB-IIa cervical carcinoma determined by a stratification analysis". Euro. J. Gynaecol. 2002, 23, 17.
52. Juan C. M., Wang P. H., Yen M. S., Lai C. R., Ng H. T., Yuan C.: "Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix". Gynecol. Oncol., 2000, 76, 103.
53. Chao H. T., Wang P. H., Tseng J. Y., Lai C. R., Chiang S. C., Yuan C. C.: "Lymphocyte infiltrated on FIGO stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival". Euro J. Gynaecol. Oncol., 1999, 20, 136.
54. Loh T. O., Wang P. H., Yen M. S., Chao K. C., Ng H. T., Yuan C. C.: "Identifying local tumor variables for operable node-negative, margin-free patients with bulky cervical carcinoma of FIGO stage IB, IIA and IIB without adjuvant therapies". Euro. J. Gynaecol. Oncol., 2001, 22, 420.
55. Yuan C. C., Ng H. T, Wang P. H.: "New strategies and advances in the management of cervical carcinoma". Gan To Kagaku Ryoho, 2002, 29 (Suppl. 1), 143.
56. Wolf J. K., Ramirez P. T.: "The molecular biology of cervical cancer". Cancer Invest., 2001, 19, 621.
57. Schindl M., Oberhuber G., Obermair A., Schoppmann S. F., Karner B., Birner P.: "Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer". Cancer Res., 2001, 61, 5703.
58. Wei L. H., Kuo M. L., Chen C. A., Cheng W. F., Cheng S. P., Hsieh F. J., Hsieh C. Y.: "Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor". Gynecol. Oncol., 2001, 82, 49.
59. Ueda M., Terai Y., Kumagai K., Ueki K., Yamaguchi H., Akise D., Ueki M.: "Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells". Gynecol. Oncol., 2001, 82, 162.
60. Tjalma W. A., Weyler J. J., Bogers J. J., Pollefliet C., Baay M., Goovaerts G. C., et al.: "The importance of biological factors (bcl-2, bax. p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer". Euro. J. Obstet. Gynecol. Reprod. Biol., 2001, 97, 223.
61. Ji M. Y., Lee Y. C., Kim K. S., Cho J. W., Jung K. Y., Kim C. H., Choo Y. K.: "Developmental patterns of Gal β 1,3(4)GlcNAc α 2,3-sialyltransferase (ST3Gal III) expression in the mouse: in situ hybridization using DIG-labeled RNA probes". Arch. Pharmacal. Res., 1999, 22, 243.
62. Kannagi R.: "Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer". Glycoconj. J., 1997, 14, 577.
63. Hakomori S. I.: "Tumor malignancy defined by aberrant glycosylation and sphingo) glycolipid metabolism". Cancer Res., 1996, 56, 5309.
64. x". Science, 1990, 250, 1130.
65. x determinant on myeloid and tumor cells". Science, 1990, 250, 1132.
66. Kansas G. S.: "Selectins and their ligands: current concepts and controversies". Blood, 1996, 88, 3259.
67. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa K., Kiso M., Kannagi R.: "Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium". Cancer Res., 1993, 53, 354.